Find News

Filter articles

Showing 31 to 40 of 3409 results

Fed Circuit split over $235m skinny label verdict

US10-08-2021Rory O'Neill

The US Court of Appeals for the Federal Circuit has reinstated a $235 million verdict against Teva in a split decision which could have major implications for skinny label generics.

7th Circuit won’t overturn spinal implant injunction

US10-08-2021Alex Baldwin

The US Court of Appeals for the Seventh Circuit has upheld a preliminary injunction from an Illinois court that blocked medical device maker Aegis Spine from selling its spinal implant.

Shionogi and Duchesnay add new patents to Osphena dispute

US05-08-2021Alex Baldwin

Pharmaceutical companies Shionogi and Duchesnay have filed a second lawsuit against Hetero labs, claiming that the company infringed two additional patents related to Osphena—a treatment for vaginal pain during sex.

Takeda faces ‘pay-for-delay’ class-action suit over anti-constipation drug

US05-08-2021Alex Baldwin

Takeda Pharmaceuticals is the target of a proposed class action that alleges the pharma giant paid to keep a generic anti-constipation drug off the market.

FTC urges Congress to step in over AbbVie antitrust claim

US03-08-2021Muireann Bolger

The US Federal Trade Commission has dropped its remaining claim in a lawsuit against AbbVie and Besins Healthcare, after the US Supreme Court declined to rule that consumers had a right to be compensated by the companies.

US Judiciary Committee advances four bills to curb antitrust pharma practices

US03-08-2021Mergers & acquisitionsAlex Baldwin

The US Senate Judiciary Committee has unanimously voted to pass four bills that aim to crack down on anti-competitive practices in the pharmaceutical industry.

Is big pharma’s antidote to the COVID-19 waiver a viable alternative?

29-07-2021Alex Baldwin

In May, a consortium of pharmaceutical companies came together to pitch a new plan to help provide more equitable access to COVID-19 vaccines.

Bio-Rad and 10X Genomics end patent fight with new licensing deal

US29-07-2021Muireann Bolger

Bio-Rad Laboratories has settled its long-running dispute with 10X Genomics over patents covering genetic analysis tech and both companies have negotiated an agreement to cross-license their products.

FDA approves milestone biosimilar insulin drug


The US Food and Drug Administration has approved the first-ever interchangeable biosimilar product, an insulin treatment for Types 1 and 2 diabetes.

New York judge denies arbitration request in $881m cannabinoid suit

US27-07-2021Alex Baldwin

A New York federal court has denied biotechnology company Amyris’ bid for arbitration in an $881 million trade secrets and patent infringement dispute with cannabis firm Lavvan.

Showing 31 to 40 of 3409 results